Review: Vaccines and Vaccination against Lumpy Skin Disease
2021
Tuppurainen, Eeva | Dietze, Klaas | Wolff, Janika | Bergmann, Hannes | Beltran-Alcrudo, Daniel | Fahrion, Anna | Lamien, Charles Euloge | Busch, Frank | Sauter-Louis, Carola | Conraths, Franz Josef | De Clercq, Kris | Hoffmann, Bernd | Knauf, Sascha
The geographical distribution of lumpy skin disease (LSD), an economically important cattle disease caused by a capripoxvirus, has reached an unprecedented extent. Vaccination is the only way to prevent the spread of the infection in endemic and newly affected regions. Yet, in the event of an outbreak, selection of the best vaccine is a major challenge for veterinary authorities and farmers. Decision makers need sound scientific information to support their decisions and subsequent actions. The available vaccine products vary in terms of quality, efficacy, safety, side effects, and price. The pros and cons of different types of live attenuated and inactivated vaccines, vaccination strategies, and associated risks are discussed. Seroconversion, which typically follows vaccination, places specific demands on the tools and methods used to evaluate the effectiveness of the LSD vaccination campaigns in the field. We aimed to give a comprehensive update on available vaccines and vaccination against LSD, to better prepare affected and at-risk countries to control LSD and ensure the safe trade of cattle.
显示更多 [+] 显示较少 [-]